Regeneron Stock Future Price Prediction

REGN
 Stock
  

USD 648.70  5.41  0.84%   

Regeneron Pharmaceuticals stock price prediction is an act of determining the future value of Regeneron Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Regeneron Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Regeneron Pharmaceuticals and does not consider all of the tangible or intangible factors available from Regeneron Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Regeneron Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Additionally, take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Regeneron Pharmaceuticals based on different types of headlines from major news networks to social media. The Regeneron stock price prediction module provides an analysis of price elasticity to changes in media outlook on Regeneron Pharmaceuticals over a specific investment horizon.
Quarterly Earnings Growth YOY
-0.73
EPS Estimate Next Quarter
10.84
Wall Street Target Price
685.7
EPS Estimate Current Quarter
9.54
Quarterly Revenue Growth YOY
-0.44
Using Regeneron Pharmaceuticals hype-based prediction, you can estimate the value of Regeneron Pharmaceuticals from the perspective of Regeneron Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Regeneron Pharmaceuticals using Regeneron Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Regeneron using crowd psychology based on the activity and movement of Regeneron Pharmaceuticals' stock price.
Regeneron Pharmaceuticals Accounts Payable Turnover is quite stable at the moment as compared to the past year. The company's current value of Accounts Payable Turnover is estimated at 34.63. Accrued Expenses Turnover is expected to rise to 11.88 this year, although the value of PPandE Turnover will most likely fall to 3.80.

Regeneron Pharmaceuticals Short Interest

A significant increase or decrease in Regeneron Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Regeneron. Short interest can provide insight into the potential direction of Regeneron Pharmaceuticals stock and how bullish or bearish investors feel about the market overall. An investor who is long Regeneron Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Regeneron Pharmaceuticals and may potentially protect profits, hedge Regeneron Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA
634.75
Short Percent
0.0299
Short Ratio
5.85
Shares Short Prior Month
2.9 M
50 Day MA
597.81
Shares Short
3.1 M

Regeneron Pharmaceuticals Hype to Price Pattern

Investor biases related to Regeneron Pharmaceuticals' public news can be used to forecast risks associated with investment in Regeneron. The trend in average sentiment can be used to explain how an investor holding Regeneron can time the market purely based on public headlines and social activities around Regeneron Pharmaceuticals. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Regeneron Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals Implied Volatility

    
  34.35  
Regeneron Pharmaceuticals' implied volatility exposes the market's sentiment of Regeneron Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regeneron Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regeneron Pharmaceuticals stock will not fluctuate a lot when Regeneron Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Regeneron Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Regeneron Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Regeneron because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Regeneron Pharmaceuticals after-hype prediction price

    
  $ 648.52  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Regeneron contract

Based on the Rule 16, the options market is currently suggesting that Regeneron Pharmaceuticals will have an average daily up or down price movement of about 2.15% per day over the life of the 2022-08-19 option contract. With Regeneron Pharmaceuticals trading at $648.7, that is roughly $13.93. If you think that the market is fully incorporating Regeneron Pharmaceuticals' daily price movement you should consider acquiring Regeneron Pharmaceuticals options at the current volatility level of 34.35%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Regeneron Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Regeneron Pharmaceuticals in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
583.83670.72672.77
Details
Naive
Forecast
LowNext ValueHigh
697.25699.30701.35
Details
15 Analysts
Consensus
LowTarget PriceHigh
575.00706.85844.00
Details
Earnings
Estimates (5)
LowProjected EPSHigh
66.3766.8767.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regeneron Pharmaceuticals. Your research has to be compared to or analyzed against Regeneron Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Regeneron Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Regeneron Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regeneron Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regeneron Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Regeneron Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Regeneron Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regeneron Pharmaceuticals' historical news coverage. Regeneron Pharmaceuticals' after-hype downside and upside margins for the prediction period are 646.47 and 650.57, respectively. We have considered Regeneron Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 648.70
646.47
Downside
648.52
After-hype Price
650.57
Upside
Regeneron Pharmaceuticals is very steady asset. Analysis and calculation of next after-hype price of Regeneron Pharmaceuticals is based on 3 months time horizon.

Regeneron Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Regeneron Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regeneron Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regeneron Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  2.07  0.00   0.00  4 Events / Month7 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
648.70648.520.03 
58.47  

Regeneron Pharmaceuticals Hype Timeline

Regeneron Pharmaceuticals is at this time traded for 648.70. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Regeneron is forecasted to decline in value after the next headline with the price expected to drop to 648.52. The average volatility of media hype impact on the company price is about 58.47%. The price decrease on the next newsis expected to be -0.03% whereas the daily expected return is at this time at 0.0%. The volatility of related hype on Regeneron Pharmaceuticals is about 258.03% with expected price after next announcement by competition of 648.7. About 88.0% of the company shares are owned by institutional investors. The book value of Regeneron Pharmaceuticals was at this time reported as 163.52. The company recorded earning per share (EPS) of 62.53. Regeneron Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days.
Additionally, take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Regeneron Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Regeneron Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Regeneron Pharmaceuticals' future price movements. Getting to know how Regeneron Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regeneron Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PFEPfizer Inc(0.52) 10 per month 1.78 (0.07)  3.00 (3.17)  7.74 
ATAIAtai Life Sciences 0.27 5 per month 4.15  0.12  8.15 (7.86)  20.29 
AAPLApple Inc 2.30 10 per month 2.00  0.09  3.42 (3.85)  8.84 
BBBYBed Bath Beyond(0.24) 8 per month 6.67  0.15  23.55 (9.94)  54.03 
COSTCostco Wholesale(3.08) 9 per month 2.62  0.0446  3.68 (2.39)  14.73 
ECLEcolab Inc 3.84 8 per month 1.80  0.0306  4.01 (3.35)  10.05 
GEGeneral Electric 2.02 9 per month 1.97  0.0274  3.33 (3.32)  8.85 
TRVThe Travelers Companies 1.99 9 per month 1.60 (0.06)  2.28 (2.33)  9.03 
HPQHp Inc 0.64 9 per month 0.00 (0.05)  4.22 (3.79)  12.62 

Regeneron Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Regeneron price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regeneron using various technical indicators. When you analyze Regeneron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Regeneron Pharmaceuticals Predictive Indicators

The successful prediction of Regeneron Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regeneron Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on analysis of Regeneron Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regeneron Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regeneron Pharmaceuticals's related companies.
 2020 2021 2022 (projected)
Receivables Turnover2.923.33.38
PPandE Turnover2.774.793.8

Story Coverage note for Regeneron Pharmaceuticals

The number of cover stories for Regeneron Pharmaceuticals depends on current market conditions and Regeneron Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regeneron Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regeneron Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Regeneron Pharmaceuticals Short Properties

Regeneron Pharmaceuticals' future price predictability will typically decrease when Regeneron Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regeneron Pharmaceuticals often depends not only on the future outlook of the potential Regeneron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regeneron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.60%
Short Percent Of Float2.76%
Float Shares103.13M
Average Daily Volume Last 10 Day628.24k
Shares Short Prior Month2.58M
Average Daily Volume In Three Month654.62k
Date Short Interest15th of July 2022
Additionally, take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.73
Market Capitalization
68.7 B
Quarterly Revenue Growth YOY
-0.44
Return On Assets
0.18
Return On Equity
0.32
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Regeneron Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.